CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion

Journal of Immunology

Volumn 167, Issue 2, 2001, Pages 1090-1096

  Hombach, A ^a   Heuser, C ^a   Marquardt, T ^a   Wieczarkowiecz, A ^a   Groneck, V ^a   Pohl, C ^a   Abken, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; CD30 ANTIGEN; CD4 ANTIGEN; FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; PERFORIN; RECOMBINANT ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL;

EID: 0035879290     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.2.1090     Document Type: Article

References (23)

1. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors
2. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells
3. In vivo activity of T cells redirected with chimeric antibody/T-cell receptor genes
4. Can combined T cell- and antibody-based immunotherapy outsmart tumor cells?
5. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
6. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
7. Immune function in mice lacking the perforin gene
8. How do cytotoxic lymphocytes kill their targets?
9. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation
10. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL
11. + cytotoxic T lymphocytes in humans
12. Humanized anti-carcinoembryonic antigen antibody: Strategies to enhance human tumor cell killing
13. CD30 specific AB1-AB2-AB3 internal image antibody network: Potential use as anti-idiotype vaccine against Hodgkin's lymphoma
14. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice
15. A retroviral vector system "STITCH" in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes
16. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA
17. An entirely humanized CD3 ζ-chain signaling receptor that directs peripheral blood T cells to specific lysis of carcinoembryonic antigen-positive tumor cells
18. T cell activation by recombinant FcεeRI γ-chain immune receptors: An extracellular spacer domain impairs antigen dependent T cell activation but not antigen recognition
19. Improved short- and long term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells
20. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma to permanently growing Hodgkin-Reed Sternberg cells
21. + cytotoxic T-lymphocyte clones
22. Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses
23. + CTL directed against herpes simplex virus-infected cells